Independent, family-owned paperboard packaging supplier to pharmaceutical, healthcare, and consumer industries celebrates 65 ...

Anima Biotech , the Tech.Bio leader in Visual Biology for drug discovery, will showcase its Lightning AI platform at the 3rd annual AI/ML-Enabled Drug Discovery Session,“Leveraging GenAI to Improve ...

Johnson & Johnson Sept. 30 notified the Health Resources and Services Administration that it is ceasing implementation of its ...

The EU's increasing reliance on pharmaceutical production from non-EU countries, particularly India and China, has raised ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

If unorthodoxy and discipline could be blended and bottled, Bob Duggan would have another multibillion-dollar product. For now, his fortunes are focused on an experimental cancer drug that wowed ...

Analyst Kostas Biliouris of BMO Capital maintained a Hold rating on BridgeBio Pharma (BBIO – Research Report), retaining the price target ...

The introduction of diclofenac led to the...decimation of these populations by up to 99.9% and now, only remnant wild ...

Union Minister of Commerce and Industry Piyush Goyal met with young Indian-origin CEOs and entrepreneurs in New York emphasising the reforms introduced under ...

Acquisition of Emglev Therapeutics to focus on discovering single-domain antibodies (sdAbs) The VIO-01 trial is currently in Phase 1 dose escalation R&D efforts maintained for optimization ...

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Zevra Therapeutics (ZVRA – Research Report) today and set a price target ...

Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter "Valerio Therapeutics" or the "Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs ...